Evidence map›Paper›PMID 37247131›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2023

Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer.

Adán Rodríguez-Gonzalez, Alberto Carmona-Bayonas, Raquel Hernandez San Gil, Patricia Cruz-Castellanos, Mónica Antoñanzas-Basa, David Lorente-Estelles, María Jose Corral, Manuel González-Moya, Oscar Alfredo Castillo-Trujillo, Emilio Esteban and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Adán Rodríguez-GonzalezDepartment of Medical Oncology, Hospital Universitario Central of Asturias, ISPA, Faculty of Medicine, University of Oviedo, Avenida de Roma S/N, Oviedo, Asturias, Spain.ORCID http://orcid.org/0000-0002-5078-139X
Alberto Carmona-BayonasDepartment of Medical Oncology, Hospital General Universitario Morales Meseguer, Murcia, Spain.ORCID http://orcid.org/0000-0002-1930-9660
Raquel Hernandez San GilDepartment of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain.ORCID http://orcid.org/0000-0003-3426-7515
Patricia Cruz-CastellanosDepartment of Medical Oncology, Hospital Universitario la Paz, Madrid, Spain.ORCID http://orcid.org/0000-0002-9837-825X
Mónica Antoñanzas-BasaDepartment of Medical Oncology, Hospital Universitario Clínico San Carlos, Madrid, Spain.ORCID http://orcid.org/0000-0002-7434-9059
David Lorente-EstellesDepartment of Medical Oncology, Hospital Provincial de Castellón, Castellón, Spain.ORCID http://orcid.org/0000-0001-7550-0657
María Jose CorralDepartment of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8278-1370
Manuel González-MoyaDepartment of Medical Oncology. Hospital QuironSalud, Seville, Spain.ORCID http://orcid.org/0000-0002-1428-2745
Oscar Alfredo Castillo-TrujilloDepartment of Medical Oncology, Hospital Universitario Central of Asturias, ISPA, Faculty of Medicine, University of Oviedo, Avenida de Roma S/N, Oviedo, Asturias, Spain.ORCID http://orcid.org/0000-0001-7479-8658
Emilio EstebanDepartment of Medical Oncology, Hospital Universitario Central of Asturias, ISPA, Faculty of Medicine, University of Oviedo, Avenida de Roma S/N, Oviedo, Asturias, Spain.ORCID http://orcid.org/0000-0002-2980-5254
Paula Jiménez-FonsecaDepartment of Medical Oncology, Hospital Universitario Central of Asturias, ISPA, Faculty of Medicine, University of Oviedo, Avenida de Roma S/N, Oviedo, Asturias, Spain. palucaji@hotmail.com.ORCID http://orcid.org/0000-0003-4592-3813
Caterina CalderonDepartment of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6956-9321
Universidad de Oviedo · ESUniversitat de Barcelona · ESFundación Hospital Provincial de Castellón · ESHospital Clínico San Carlos · ESHospital General Universitario Morales Meseguer · ESHospital Quirónsalud Barcelona · ESHospital Universitario de Canarias · ESHospital Universitario La Paz · ES

Funding

AstraZeneca España ES-2020-3172FSEOM FSEOM 2018
6 · The paper itself

Abstract

introductionThis study investigated the impact of systemic cancer therapy on the quality of life, mental well-being, and life satisfaction of cancer patients.

methodsThis prospective study was promoted by the Spanish Society of Medical Oncology (SEOM) and enrolled patients with localized, resected, or unresectable advanced cancer from 15 Spanish medical oncology departments. Patients completed surveys on quality of life (EORTC-QoL-QLQ-C30), psychological distress (BSI-18) and life satisfaction (SWLS) before and after systemic cancer treatment.

resultsThe study involved 1807 patients, 944 (52%) having resected, localized cancer, and 863 with unresectable advanced cancer. The mean age was 60 years, and 53% were female. The most common types of localized cancer were colorectal (43%) and breast (38%), while bronchopulmonary (32%), non-colorectal digestive (23%), and colorectal (15%) were the most frequent among those with advanced cancer. Before systemic treatment, patients with advanced cancer had poorer scores than those with localized cancer on physical, role, emotional, cognitive, social limitations, symptoms, psychological distress, and life satisfaction (all p < 0.001), but there were no differences in financial hardship. Patients with localized cancer had greater life satisfaction and better mental well-being than those with advanced cancer before systemic treatment (p < 0.001). After treatment, patients with localized cancer experienced worsening of all scales, symptoms, and mental well-being (p < 0.001), while patients with advanced disease had a minor decline in quality of life. The impact on quality of life was greater on all dimensions except economic hardship and was independent of age, cancer location, and performance status in participants with resected disease after adjuvant chemotherapy.

conclusionIn conclusion, our study highlights that systemic cancer treatment can improve quality of life in patients with advanced cancer, while adjuvant treatments for localized disease may have a negative impact on quality of life and psychological well-being. Therefore, treatment decisions should be carefully evaluated on an individual basis.

Indexed as

Colorectal NeoplasmsQuality of LifeEmotionsFemaleHumansMaleMiddle AgedProspective StudiesPsychological Well-BeingSurveys and QuestionnairesCancerPsychological distressQuality of lifeSatisfaction with lifeTreatment

Identifiers

PMID37247131
OpenAlexW4378610391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.